Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill R Turner

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Elife|January 27, 2025
Finding new ways to treat overdosesJill R Turner, Jocelyn Martin
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2005
Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypesJill R Turner, Kenneth J Kellar
Advances in Pharmacology (San Diego, Calif.)|March 11, 2024
Nicotine use disorder and Neuregulin 3: Opportunities for precision medicineTaylor R Elder, Jill R Turner
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 25, 2010
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and vareniclineJill R Turner, Laura M Castellano, Julie A Blendy
Handbook of Experimental Pharmacology|July 4, 2019
Molecular Mechanisms Associated with Nicotine Pharmacology and DependenceChristie D Fowler, Jill R Turner, M Imad Damaj
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2014
Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptorsNicole L Yohn, Jill R Turner, Julie A Blendy
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 31, 2013
Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administrationPavel I Ortinski, Jill R Turner, R Christopher Pierce
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2010
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behaviorJill R Turner, Laura M Castellano, Julie A Blendy
Neuropharmacology|May 29, 2020
Glial cells as therapeutic targets for smoking cessationMohit Kumar, Adewale Adeluyi, Erin L Anderson, et al.
International Review of Neurobiology|October 17, 2015
Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid DisordersMiranda L Fisher, Anu Loukola, Jaakko Kaprio, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Elife|January 27, 2025
Finding new ways to treat overdosesJill R Turner, Jocelyn Martin
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2005
Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypesJill R Turner, Kenneth J Kellar
Advances in Pharmacology (San Diego, Calif.)|March 11, 2024
Nicotine use disorder and Neuregulin 3: Opportunities for precision medicineTaylor R Elder, Jill R Turner
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 25, 2010
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and vareniclineJill R Turner, Laura M Castellano, Julie A Blendy
Handbook of Experimental Pharmacology|July 4, 2019
Molecular Mechanisms Associated with Nicotine Pharmacology and DependenceChristie D Fowler, Jill R Turner, M Imad Damaj
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2014
Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptorsNicole L Yohn, Jill R Turner, Julie A Blendy
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 31, 2013
Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administrationPavel I Ortinski, Jill R Turner, R Christopher Pierce
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2010
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behaviorJill R Turner, Laura M Castellano, Julie A Blendy
Neuropharmacology|May 29, 2020
Glial cells as therapeutic targets for smoking cessationMohit Kumar, Adewale Adeluyi, Erin L Anderson, et al.
International Review of Neurobiology|October 17, 2015
Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid DisordersMiranda L Fisher, Anu Loukola, Jaakko Kaprio, et al.
Pageof 5